News

Dutch Start-up receives 2.5 million from Europe to block Cancer’s spre


TRY IT NOW

Sign up online today & collaborate

or click here to find out more

Dutch Start-up receives 2.5 million from Europe to block Cancer’s spreading


Date: 28/08/2015

The Eurostars program supports the Dutch start-up Oncodrone with fresh money to bring its metastasis-blocking drug towards clinical trials.

Even with a promising technology, it’s not easy to succeed in the biotech field. The Eurostars program helps small companies through the tough starting phase. This year, the 2013 founded biotech start-up Oncodrone gets a 2.5 million grant that will allow it to bring its one and only drug OCD155 through pre-clinical development.

The drug addresses the most terrifying feature of cancer: the ability to spread throughout the body. To do this, it inhibits a process called epithelial-to-mesenchymal transition (EMT). As the name says, epithelial cells gain characteristics from mesenchymal cells during this procedure, such as high mobility. This property is crucial for cancer cells to migrate.

For more click here

Source: Labiotech

© Catalyst Innovation Portal 2019